In Silico Study, Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives

被引:0
|
作者
Karthick, Kamaraj [1 ]
Abishek, Kamaraj [2 ]
Jemima, Ebenezer Angel [3 ]
机构
[1] Rajalakshmi Inst Technol, Dept Chem, Chennai 600124, Tamil Nadu, India
[2] Sadakathullah Appa Coll, Dept Zool, Tirunelveli, Tamil Nadu, India
[3] Trichy Res Inst Biotechnol Pvt Ltd, Trichy, India
来源
BIOINFORMATICS AND BIOLOGY INSIGHTS | 2024年 / 18卷
关键词
Benzimidazole derivatives; in silico study; protein kinase and molecular docking; ANTICANCER; MORTALITY; AGENTS;
D O I
10.1177/11779322241247635
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Kinase enzymes play an important role in cellular proliferation, and inhibition of their activity is a major goal of cancer therapy. Protein kinase inhibitors as benzimidazole derivatives can be applied for prevention or treatment of cancers through inhibition of cell proliferation. To evaluate their protein kinase inhibitory effects, as well as the in silico study for active benzimidazole derivatives. Benzimidazole derivatives has presented significant therapeutic potential against several disorders and known to have numerous biological activities (such as antibacterial, antiviral and anti-inflammatory). Benzimidazole derivatives have shown significant potential in the reduction of viral load as well as in enhancing immunity. To forecast absorption, distribution, metabolism, excretion and toxicity, simply known as ADMET and the Lipinski rule of five parameters of the examined substances, the admetSAR and Swiss ADME were used. The ADMET predictions revealed that the compounds had good and safe pharmacokinetic features, making them acceptable for further development as therapeutic candidates in clinical trials. This study primarily focused on blocking 2 key targets of kinase proteins (CDK4/CycD1 and Aurora B). 2-Phenylbenzimidazole has shown the greatest inhibitory potential (with a binding energy of -8.2 kcal/mol) against protein kinase inhibitors. This study results would pave the potential lead medication for anticancer therapeutic strategies.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: an in-silico approach
    Sonal Dubey
    P. Prabitha
    Sakshi Bhardwaj
    Ekta Singh
    Structural Chemistry, 2019, 30 : 263 - 272
  • [22] In silico investigation of falcipain-2 inhibition by hybrid benzimidazole-thiosemicarbazone antiplasmodial agents: A molecular docking, molecular dynamics simulation, and kinetics study
    Nkungli, Nyiang Kennet
    Fouegue, Aymard Didier Tamafo
    Tasheh, Stanley Numbonui
    Bine, Fritzgerald Kogge
    Ul Hassan, Abrar
    Ghogomu, Julius Numbonui
    MOLECULAR DIVERSITY, 2024, 28 (02) : 475 - 496
  • [23] In silico investigation of falcipain-2 inhibition by hybrid benzimidazole-thiosemicarbazone antiplasmodial agents: A molecular docking, molecular dynamics simulation, and kinetics study
    Nyiang Kennet Nkungli
    Aymard Didier Tamafo Fouegue
    Stanley Numbonui Tasheh
    Fritzgerald Kogge Bine
    Abrar Ul Hassan
    Julius Numbonui Ghogomu
    Molecular Diversity, 2024, 28 : 475 - 496
  • [24] Synthesis, α-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives
    Taha, Muhammad
    Noreen, Tayyaba
    Imran, Syahrul
    Nawaz, Fasial
    Chigurupati, Sridevi
    Selvaraj, Manikandan
    Rahim, Fazal
    Ismail, Nor Hadiani
    Kumar, Ashok
    Mosaddik, Ashik
    Alghamdi, Abdullah M.
    Alqahtani, Yousif Abdulrahman Nasser
    Alqahtani, Abdulaziz Abdulrahman Nasser
    MEDICINAL CHEMISTRY RESEARCH, 2019, 28 (11) : 2010 - 2022
  • [25] Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives
    Taha, Muhammad
    Shah, Syed Adnan Ali
    Afifi, Muhammad
    Imran, Syahrul
    Sultan, Sadia
    Rahim, Fazal
    Khan, Khalid Mohammed
    BIOORGANIC CHEMISTRY, 2018, 77 : 586 - 592
  • [26] Synthesis, α-amylase inhibition and molecular docking study of bisindolylmethane sulfonamide derivatives
    Muhammad Taha
    Tayyaba Noreen
    Syahrul Imran
    Fasial Nawaz
    Sridevi Chigurupati
    Manikandan Selvaraj
    Fazal Rahim
    Nor Hadiani Ismail
    Ashok Kumar
    Ashik Mosaddik
    Abdullah M. Alghamdi
    Yousif Abdulrahman nasser alqahtani
    Abdulaziz Abdulrahman nasser alqahtani
    Medicinal Chemistry Research, 2019, 28 : 2010 - 2022
  • [27] Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study
    Qiao, Sennan
    Zhang, Hansi
    Sun, Fei
    Jiang, Zhenyan
    MOLECULES, 2021, 26 (18):
  • [28] Synthesis, molecular docking, α-glucosidase inhibition, and antioxidant activity studies of novel benzimidazole derivatives
    Singh, Gagandeep
    Singh, Amanjot
    Singh, Varinder
    Verma, Raman K.
    Tomar, Jyoti
    Mall, Rajiv
    MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (10) : 1846 - 1866
  • [29] Synthesis, molecular docking, α-glucosidase inhibition, and antioxidant activity studies of novel benzimidazole derivatives
    Gagandeep Singh
    Amanjot Singh
    Varinder Singh
    Raman K. Verma
    Jyoti Tomar
    Rajiv Mall
    Medicinal Chemistry Research, 2020, 29 : 1846 - 1866
  • [30] Synthesis, molecular docking, in silico ADME, and EGFR kinase inhibitor activity studies of some new benzimidazole derivatives bearing thiosemicarbazide, triazole, and thiadiazole
    Celik, Ismail
    Ayhan-Kilcigil, Gulgun
    Karayel, Arzu
    Guven, Berna
    Onay-Besikci, Arzu
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2022, 59 (02) : 371 - 387